US Pen Needles Market Size, Share & Growth
The US pen needles market, valued at US$0.85 billion in 2025, stood at US$0.93 billion in 2026 and is projected to advance at a resilient CAGR of 10.4% from 2026 to 2031, culminating in a forecasted valuation of US$1.53 billion by the end of the period. Drivers include rising diabetes prevalence, aging, and obesity, and strong adoption of insulin pens that increase per-patient needle consumption. Restraints encompass pricing pressure, commoditization, reimbursement variability, and demand displacement from GLP-1 therapies.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9759386
- By type, standard pen needles dominated the market, with a share of 83.4%, in 2025.
- By length, 8mm segment dominated the market, with a share of 29.7% in 2024
- By application, insulin therapy will be the fastest-growing segment in the forecast period.
- By mode of purchase, the over-the-counter segment dominated the market, with a share of 34.8% in 2024
- By setting, the home care segment is expected to register the highest CAGR of 10.8%.
- Embecta Corp., Novo Norisk A/S, and B. Braun SE were identified as Star players in the US pen needles market, as they have focused on innovation and have broad industry coverage and strong operational & financial strengths.
- AdvaCare Pharma, MHC Medical Products, and Wellion distinguished themselves among startups and SMEs due to their strong product portfolio and business strategy
The US pen needles market is driven by rising diabetes prevalence, an ageing population, and growing insulin-pen adoption that boosts per-patient consumption, while pricing pressure, reimbursement variability, and shifting demand due to GLP-1 therapies act as key restraints; however, substantial opportunities exist in safety-engineered and ultra-low-trauma needle innovation, smart/connected disposables, direct-to-patient subscription models, and OEM supply partnerships that enable premiumization, improved adherence, and stronger penetration across pharmacy, e-commerce, and home-care channels